SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 102 400 KRW -1.54%
Market Cap: 8T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SK Biopharmaceuticals Co Ltd
Other Equity Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Other Equity
â‚©8B
CAGR 3-Years
58%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Other Equity
â‚©98.3B
CAGR 3-Years
-15%
CAGR 5-Years
1%
CAGR 10-Years
2%
Hanmi Science Co Ltd
KRX:008930
Other Equity
â‚©74.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
41%
Hanmi Pharm Co Ltd
KRX:128940
Other Equity
-â‚©14.6B
CAGR 3-Years
-21%
CAGR 5-Years
-21%
CAGR 10-Years
-9%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Other Equity
â‚©59B
CAGR 3-Years
165%
CAGR 5-Years
79%
CAGR 10-Years
34%
C
Celltrion Pharm Inc
KOSDAQ:068760
Other Equity
â‚©12.5B
CAGR 3-Years
27%
CAGR 5-Years
26%
CAGR 10-Years
12%

See Also

What is SK Biopharmaceuticals Co Ltd's Other Equity?
Other Equity
8B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Other Equity amounts to 8B KRW.

What is SK Biopharmaceuticals Co Ltd's Other Equity growth rate?
Other Equity CAGR 5Y
4%

Over the last year, the Other Equity growth was -4%. The average annual Other Equity growth rates for SK Biopharmaceuticals Co Ltd have been 58% over the past three years , 4% over the past five years .

Back to Top